When our immune system comes into contact with the SARS-CoV-2 coronavirus, it fights back and produces antibodies. A similar immune response is triggered by coronavirus vaccines. However, there is still little data available ...
Mar 18, 2022
0
7
The World Health Organization has given emergency approval to a coronavirus vaccine made by U.S.-based Novavax and the Serum Institute of India, paving the way for its inclusion in the U.N.-backed program to get such vaccines ...
Dec 17, 2021
0
4
When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving treatment. Now, three years ...
Nov 29, 2023
0
65
When SARS-CoV-2 enters the human body, the virus' spike protein binds to a cell, allowing the virus to infiltrate and begin replicating.
Jan 24, 2024
0
3
An experimental "decoy" has provided long-term protection from infection by the pandemic virus in mice, a new study finds.
May 30, 2023
0
48
Two new omicron subvariants, BQ.1 and BQ.1.1, are quickly gaining traction in the US, collectively accounting for 27% of infections as of October 29. Both are descendants of BA.5, the omicron variant that has dominated around ...
Oct 31, 2022
0
12
Scientists at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) have identified a promising drug candidate for the treatment of multi-inflammatory syndrome in children (MIS-C), they report in Clinical ...
Feb 24, 2022
0
4
As public health officials around the world contend with the latest surge of the COVID-19 pandemic, researchers at Drexel University have created a computer model that could help them be better prepared for the next one. ...
Sep 1, 2022
1
72
Researchers at the Institute of Human Virology (IHV) at the University of Maryland School of Medicine have published a new study in the Journal of Infectious Diseases investigating the antibody response following SARS-CoV-2 ...
Mar 18, 2024
0
4
When new COVID variant BA.2.86 emerged in late July, scientists had concerns about its ability to evade immunity. But early lab tests seem to be easing those fears, as well as concerns over the variant's ability to spread ...
Sep 5, 2023
0
9
